A Molecular Study of Aspirin and Tenofovir Using Gold/Dextran Nanocomposites and Surface-Enhanced Raman Spectroscopy

In this study, we show how surface enhanced Raman spectroscopy (SERS) can be used to monitor the molecular behaviour of aspirin and tenofovir as a means of screening medication for quality control purposes. Gold-coated slides combined with gold/dextran nanoaggregates were used to provide signal enhancement of the drugs using SERS. Aspirin (10% w/v) and tenofovir (20% v/v) were analysed in the presence of the nanomaterials to determine trends in molecular response to changes in gold/dextran concentrations. Qualitative analysis of the functional groups showed specific trends where the peak area increased with polarizability, electron density and decreased atomic radii. Steric hinderance effects also affected the trends in peak area due to the amount of gold/dextran nanoparticles in solution. Statistical analysis provided accurate and precise linear relationships (R2 = 0.99) for the ester and adenine functional groups of aspirin and tenofovir, respectively. From the above findings, the combined use of gold nano-scaffolds and gold/dextran nanomaterials amplified the Raman signal from the drugs to allow for systematic evaluation of their molecular properties. Although more experiments to correlate the findings are still needed, this SERS approach shows great potential as a screening method in the quality control of medications.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:27

Enthalten in:

Molecules (Basel, Switzerland) - 27(2022), 8 vom: 15. Apr.

Sprache:

Englisch

Beteiligte Personen:

Thobakgale, Setumo Lebogang [VerfasserIn]
Ombinda-Lemboumba, Saturnin [VerfasserIn]
Mthunzi-Kufa, Patience [VerfasserIn]

Links:

Volltext

Themen:

7440-57-5
99YXE507IL
Aspirin
Chemical sensors
Dextran
Dextrans
Gold
Gold nanoparticles
Journal Article
R16CO5Y76E
SERS
Tenofovir

Anmerkungen:

Date Completed 26.04.2022

Date Revised 16.07.2022

published: Electronic

Citation Status MEDLINE

doi:

10.3390/molecules27082554

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM339879238